A
Adil A. Abdalla
Researcher at Washington University in St. Louis
Publications - 18
Citations - 307
Adil A. Abdalla is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Reflux esophagitis & Microscopic colitis. The author has an hindex of 6, co-authored 18 publications receiving 268 citations. Previous affiliations of Adil A. Abdalla include National Institutes of Health & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
The Mayo Dysphagia Questionnaire-30: Documentation of Reliability and Validity of a Tool for Interventional Trials in Adults with Esophageal Disease
Judith McElhiney,Matthew R. Lohse,Amindra S. Arora,Joanna M. Peloquin,Debra M. Geno,Melissa M. Kuntz,Felicity B. Enders,Mary Fredericksen,Adil A. Abdalla,Yulia Krotova Khan,Nicholas J. Talley,Nancy N. Diehl,Timothy J. Beebe,Ann M. Harris,Gianrico Farrugia,Darlene E. Graner,Joseph A. Murray,G. Richard Locke,Rayna Grothe,Michael D. Crowell,Dawn L. Francis,April B. Grudell,Tushar S. Dabade,Angelica Ramirez,MhdMaan Alkhatib,Jeffrey A. Alexander,Jessica L. Kimber,Ganapathy A. Prasad,Alan R. Zinsmeister,Yvonne Romero +29 more
TL;DR: The MDQ-30 is an easy-to-complete tool to evaluate reliably dysphagia symptoms over the last 30 days and its feasibility, reproducibility, and concurrent validity are concluded.
Journal ArticleDOI
Outcomes of Patients With Microscopic Colitis Treated With Corticosteroids: A Population-Based Study
Nicole Gentile,Adil A. Abdalla,Sahil Khanna,Thomas C. Smyrk,William J. Tremaine,William A. Faubion,Patricia P. Kammer,William J. Sandborn,Edward V. Loftus,Darrell S. Pardi +9 more
TL;DR: Patients with MC often respond to corticosteroid therapy, but with a high relapse rate, and patients treated with budesonide had a higher response rate and a lower risk of recurrence than prednisone.
Journal ArticleDOI
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C
Yaron Rotman,Mazen Noureddin,Jordan J. Feld,Jeremie Guedj,Jeremie Guedj,Jeremie Guedj,Michael Witthaus,Hwalih Han,Yoon J. Park,Su-Hyung Park,Theo Heller,Marc G. Ghany,Edward Doo,Christopher Koh,Adil A. Abdalla,Naveen Gara,Souvik Sarkar,Emmanuel Thomas,Golo Ahlenstiel,Birgit Edlich,Rachel Titerence,Leah Hogdal,Barbara Rehermann,Harel Dahari,Harel Dahari,Harel Dahari,Alan S. Perelson,Jay H. Hoofnagle,T. Jake Liang +28 more
TL;DR: Ribavirin is a weak antiviral but its clinical effect seems to be mediated by a separate, indirect mechanism, which may act to reset IFN-responsiveness in HCV-infected liver.
Journal ArticleDOI
Durability of Antibody Response Against Hepatitis B Virus in Healthcare Workers Vaccinated as Adults
Naveen Gara,Adil A. Abdalla,Elenita Rivera,Xiongce Zhao,JM Werner,T. Jake Liang,Jay H. Hoofnagle,Barbara Rehermann,Marc G. Ghany +8 more
TL;DR: The rapid and robust response to a booster vaccine suggests a long-lasting amnestic response and Hepatitis B vaccination provides long-term protection against hepatitis B and booster vaccination does not appear to be necessary in HCWs.
Journal ArticleDOI
The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
TL;DR: HBs antigen vaccine-induced immunity protects against future infection but does not provide sterilizing immunity, as evidenced by HBcore- and polymerase-specific CD8(+) T cells in vaccinated health care workers with occupational exposure to HBV.